Resona Asset Management Co. Ltd. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 199,019 shares of the medical equipment provider’s stock after selling 21,996 shares during the period. Resona Asset Management Co. Ltd. owned 0.06% of Intuitive Surgical worth $81,063,000 as of its most recent filing with the SEC.
Several other large investors also recently modified their holdings of ISRG. Dogwood Wealth Management LLC lifted its position in shares of Intuitive Surgical by 178.3% during the 3rd quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 41 shares during the period. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical in the third quarter valued at $27,000. John Boyer Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. Compass Wealth Management LLC bought a new position in shares of Intuitive Surgical during the 3rd quarter worth about $29,000. Finally, Compass Financial Management LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $399.06 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a market cap of $138.33 billion, a PE ratio of 48.25, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45. The stock has a fifty day moving average of $423.51 and a 200-day moving average of $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the prior year, the business posted $2.40 earnings per share. The company’s revenue was up 21.7% on a year-over-year basis. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of the company’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the transaction, the director directly owned 1,150 shares in the company, valued at $529,000. This represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,363 shares of company stock worth $17,738,749 in the last ninety days. Insiders own 0.60% of the company’s stock.
More Intuitive Surgical News
These are some of the ISRG news items that stood out recently:
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Analyst Upgrades and Downgrades
Several research firms recently issued reports on ISRG. BTIG Research lifted their price target on shares of Intuitive Surgical from $454.00 to $513.00 and gave the company a “buy” rating in a research report on Wednesday. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a report on Thursday, July 30th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. TD Cowen restated a “buy” rating and issued a $485.00 target price on shares of Intuitive Surgical in a research note on Monday, October 19th. Finally, BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $495.90.
Check Out Our Latest Stock Analysis on ISRG
Intuitive Surgical Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
See Also
- Five stocks we like better than Intuitive Surgical
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
